Researchers at the British Museum and Durham University in the U.K. have located a skeleton more than 3,000 years old that they say represents the oldest complete example of a human being with metastatic cancer.
Pairing the diabetes drug, metformin, with chemoradiation therapy treatment for aggressive lung cancer may slow tumor growth and recurrence, according to researchers at the Perelman School of Medicine at the University of Pennsylvania.
Following the National Lung Screening Trial, which demonstrated a 20 percent reduction in lung cancer mortality for low-dose CT screening in high-risk patients, some have clamored for expanded CT screening efforts.
Research published recently in the New England Journal of Medicine (NEJM) looked at a predictive tool that estimates the probability that lung nodules detected through low-dose CT screening are malignant. For colorful take on the findings, check out the accompanying NEJM Quick Take animation.
Last month, a study published in The New England Journal of Medicine (NEJM) demonstrated how radium-223 could reduce the risk of death in patients with castration-resistant prostate cancer by targeting bone metastases, a common complication.
Researchers at Purdue University in West Lafayette, Ind., are working an imaging technology that combines atomic force microscopy and nuclear MR to simultaneously study the mechanical and biochemical behavior of cells.
Exact Sciences has developed a stool-based screening test that detected 92 percent of cancers found on colonoscopy and 42 percent of precancerous polyps. The results fell shy of the company’s goal of a 50 percent polyp detection rate, according to an article in the New York Times; however, Exact Sciences indicated its plans to file for FDA approval of its Cologuard test.